Markets
Tendies
@tendies
Bought EYEN
Shares
up 25.8%
At 0.12, Exited 0.16
I think $EYEN is priced too low right now, especially with solid tech in Optejet and MydCombi. Despite the challenges, I believe there's potential for...
Read
More
Thesis
I think $EYEN is priced too low right now, especially with solid tech in Optejet and MydCombi. Despite the challenges, I believe there's potential for a rebound, and I personally see it hitting around $0.60. This could be a great opportunity if you're willing to embrace some risk.
Go back
Mark
@markmast...
Bought EYEN
Shares
down -35.93%
At 0.1, Now 0.06
Low price target or 2, high of 7, very undervalued
Thesis
Low price target or 2, high of 7, very undervalued
Go back
Tendies
@tendies
Bought EYEN
Shares
down -46.29%
At 0.87, Exited 0.47
EYEN is incredibly undervalued and with their FDA-approved products and multiple partnerships, I believe this stock is poised for significant gains. A...
Read
More
Thesis
EYEN is incredibly undervalued and with their FDA-approved products and multiple partnerships, I believe this stock is poised for significant gains. Analysts predict it could reach $8 this year, so it's a solid long-term investment opportunity.
Go back
Tendies
@tendies
Bought EYEN
Shares
down -46.29%
At 0.87, Exited 0.47
EYEN is currently undervalued and has multiple FDA-approved products. They're releasing second quarter results soon and have big plans for mid-2024. A...
Read
More
Thesis
EYEN is currently undervalued and has multiple FDA-approved products. They're releasing second quarter results soon and have big plans for mid-2024. Analysts predict significant gains. It's a great time to invest in EYEN for long-term gains.
Go back
